Volume 14, Issue 11 (11-2016)                   IJRM 2016, 14(11): 699-704 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Fathizadeh S, Amani R, Haghighizadeh M H, Hormoznejad R. Comparison of serum zinc concentrations and body antioxidant status between young women with premenstrual syndrome and normal controls: A case-control study. IJRM 2016; 14 (11) :699-704
URL: http://ijrm.ir/article-1-706-en.html
Comparison of serum zinc concentrations and body antioxidant status between young women with premenstrual syndrome and normal controls: A case-control study
Sanaz Fathizadeh1 , Reza Amani * 2, Mohammad Hossein Haghighizadeh3 , Razieh Hormoznejad1
1- Nutrition and Metabolic Disease Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2- Department of Nutrition, Health Research Institute, Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran , amani-r@ajums.ac.ir
3- Department of Biostatistics, School of Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Abstract:   (2901 Views)
Background: Premenstrual syndrome (PMS) is one of the important health problems with high incidence in young women. The exact cause of this syndrome is not clear and some theories have been declared from hormonal factors to nutritional disorders.
Objective: We investigated the correlation between serum zinc and antioxidant status with PMS.
Materials and Methods: In this case-control study, forty eight young girls were selected from a total sample of 110 students residing at university dormitories including PMS (n=23) and healthy (n=25) groups based on PMS questionnaire. Dietary intake questionnaire and blood samples were collected from all participants. Serum total antioxidant capacity (TAC) and zinc concentrations were also measured.
Results: Serum TAC and zinc concentrations were lower in PMS patients compared with healthy groups (p<0.01 and p<0.05, respectively). Healthy controls consumed lower servings of hydrogenated oils (p<0.05). There were significant differences in terms of muscle mass between the PMS and healthy groups (p<0.05). Both serum TAC and zinc levels were negatively correlated to PMS scores (r=-0.39, p<0.05 and r= -0.36; p<0.05, respectively).
Conclusion: This study shows that higher TAC and zinc serum levels are associatedwith lower risk of PMS. PMS cases have more hydrogenated oils than their normalcounterparts
Keywords: Premenstrual syndrome, Total antioxidant capacity, Serum zinc concentrations, Young women.
Full-Text [PDF 476 kb]   (834 Downloads) |   |   Full-Text (HTML)  (591 Views)  
Type of Study: Original Article |
References
1. Pinar G, Colak M, Oksuz E. Premenstrual Syndrome in Turkish college students and its effects on life quality. Sex Reprod Healthcare 2011; 2: 21-27. [DOI:10.1016/j.srhc.2010.10.001]
2. Masoumi SZ, Ataollahi M, Oshvandi K. Effect of Combined Use of Calcium and Vitamin B6 on Premenstrual Syndrome Symptoms: a Randomized Clinical Trial. J Caring Sci 2016; 5: 67-73. [DOI:10.15171/jcs.2016.007]
3. Nobles CJ, Thomas JJ, Valentine SE, Gerber MW, Vaewsorn AS, Marques L. Association of premenstrual syndrome and premenstrual dysphoric disorder with bulimia nervosa and binge-eating disorder in a nationally representative epidemiological sample. Int J Eat Disord 2016; 49: 641-650 [DOI:10.1002/eat.22539]
4. Ozgoli G, Selselei EA, Mojab F, Majd HA. A randomized, placebo-controlled trial of Ginkgo biloba L. in treatment of premenstrual syndrome. J Altern Complement Med 2009; 15: 845-851. [DOI:10.1089/acm.2008.0493]
5. Darabi F, Rasaie N, Jafarirad S. The Relationship Between Premenstrual Syndrome and Food Patterns in University Student Girls. Jundishapur J Health Res 2014; 5: e26656. [DOI:10.5812/jjhr.26656]
6. Kleinstauber M, Witthoft M, Hiller W. Cognitive-behavioral and pharmacological interventions for premenstrual syndrome or premenstrual dysphoric disorder: a meta-analysis. J Clin Psychol Med Set 2012; 19: 308-319. [DOI:10.1007/s10880-012-9299-y]
7. Farahani HN, Ashthiani AR, Masihi MS. Study on serum zinc and selenium levels in epileptic patients. Neurosciences (Riyadh) 2013; 18: 138-142.
8. Tabarroki SH, Amiri Z, Tabarroki E, Ozgoli G. Influence of premenstrual syndrome on energy and nutrient intake. J Shahid Beheshti School Nurs Midwif 2012; 21: 37-44.
9. Lustyk MKB, Gerrish W. Premenstrual syndrome and premenstrual dysphoric disorder: issues of quality of life, stress and exercise. Handbook of Disease Burdens and Quality of Life Measures. 2010; 22: 1951-75.
10. Imai A, Ichigo S, Matsunami K, Takagi H. Premenstrual syndrome: management and pathophysiology. Clin Exp Obstet Gynecol 2015; 42: 123-128.
11. Fanaei H, Khayat S, Kasaeian A, Javadimehr M. Effect of curcumin on serum brain-derived neurotrophic factor levels in women with premenstrual syndrome: A randomized, double-blind, placebo-controlled trial. Neuropeptides 2016; 56: 25-31. [DOI:10.1016/j.npep.2015.11.003]
12. Amani R, Saeidi S, Nazari Z, Nematpour S. Correlation between dietary zinc intakes and its serum levels with depression scales in young female students. Biol Trace Elem Res 2010; 137: 150-158. [DOI:10.1007/s12011-009-8572-x]
13. Mitsuya H, Omata N, Kiyono Y, Mizuno T, Murata T, Mita K, et al. The co-occurrence of zinc deficiency and social isolation has the opposite effects on mood compared with either condition alone due to changes in the central norepinephrine system. Behav Brain Res 2015; 284: 125-130. [DOI:10.1016/j.bbr.2015.02.005]
14. Zhao D, Ma G, Zhang X, He Y, Li M, Han X, et al. Zinc Finger Homeodomain Factor Zfhx3 is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity. J Biol Chem 2016; 291: 12809-12820. [DOI:10.1074/jbc.M116.719377]
15. Teimoori B, Ghasemi M, Hoseini ZS, Razavi M. The Efficacy of Zinc Administration in the Treatment of Primary Dysmenorrhea. Oman Med J 2016; 31: 107-111. [DOI:10.5001/omj.2016.21]
16. Jeon Y, Yoon JD, Cai L, Hwang SU, Kim E, Zheng Z, et al. Supplementation of zinc on oocyte in vitro maturation improves preimplatation embryonic development in pigs. Theriogenology 2014; 82: 866-874. [DOI:10.1016/j.theriogenology.2014.06.021]
17. Bertone-Johnson ER, Hankinson SE, Johnson SR, Manson JE. A simple method of assessing premenstrual syndrome in large prospective studies. J Reprod Med 2007; 52: 779-786.
18. Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Report 2003; 8: 365-370. [DOI:10.1179/135100003225003393]
19. Duvan CI, Cumaoglu A, Turhan NO, Karasu C, Kafali H. Oxidant/antioxidant status in premenstrual syndrome. Arch Gynecol Obstet 2011; 283: 299-304. [DOI:10.1007/s00404-009-1347-y]
20. Kalia G, Sudheendran S, Rao A. Antioxidant status and lipid peroxidation in premenstrual syndrome: a preliminary study. Clin Chim Acta 2001; 309: 97-99. [DOI:10.1016/S0009-8981(01)00498-3]
21. Rossignol AM, Bonnlander H. Rossignol and Bonnlander Respond. Am J Public Health Res 1991; 81: 1674. [DOI:10.2105/AJPH.81.12.1674]
22. Ryan KJ, khosro sobhanian. Kistner's gynecology and women's health: Tehran, Golbaran, 2005; 4: 65-67.
23. Ahangari A, Backstrom T, Innala E, Andersson C, Turkmen S. Acute intermittent porphyria symptoms during the menstrual cycle. Intern Med J 2015; 45: 725-731. [DOI:10.1111/imj.12784]
24. Veissi M, Anari R, Amani R, Shahbazian H, Latifi SM. Mediterranean diet and metabolic syndrome prevalence in type 2 diabetes patients in Ahvaz, southwest of Iran. Diabetes Metab Syndrome Clin Res Rev 2016; 10: 26-29 . [DOI:10.1016/j.dsx.2016.01.015]
25. Rakhshandehroo E, Razavi S, Nazifi S, Farzaneh M, Mobarraei N. Dynamics of the enzymatic antioxidants during experimental caprine coccidiosis. Parasitol Res 2013; 112: 1437-1441. [DOI:10.1007/s00436-013-3273-y]
26. Burtis C, Ashwood E, Bruns O. Trace elements. Tietz Textbook of Clinical Chemistry. 3rd Ed. Philadelphia, WB Saunders Co.; 1999: 505-507.
27. Verma RK, Chellappan DK, Pandey AK. Review on treatment of premenstrual syndrome: from conventional to alternative approach. J Basic Clin Physiol Pharmaco. 2014; 25: 319-327. [DOI:10.1515/jbcpp-2013-0072]
28. Abdollahifard S, Rahmanian Koshkaki A, Moazamiyanfar R. The effects of vitamin B1 on ameliorating the premenstrual syndrome symptoms. Glob J Health Sci 2014; 6: 144-153. [DOI:10.5539/gjhs.v6n6p144]
29. Bertone-Johnson ER, Hankinson SE, Forger NG, Powers SI, Willett WC, Johnson SR, et al. Plasma 25-hydroxyvitamin D and risk of premenstrual syndrome in a prospective cohort study. BMC Womens Health 2014; 14: 56. [DOI:10.1186/1472-6874-14-56]
30. Bilici M, Efe H, Köroğlu MA, Uydu HA, Bekaroğlu M, Değer O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 2001; 64: 43-51. [DOI:10.1016/S0165-0327(00)00199-3]
31. Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Report 2013; 8: 365-370. [DOI:10.1179/135100003225003393]
32. Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S. Major depressive disorder is accompanied with oxidative stress: short‐term antidepressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol Clin Exp 2007; 22: 67-73. [DOI:10.1002/hup.829]
33. Ghodake SR, Suryakar AN, Kulhalli PM, Padalkar RK, Shaikh AK. A study of oxidative stress and influence of antioxidant vitamins supplementation in patients with major depression. Curr Neurobiol 2012; 3: 107-111.
34. Longhi R, Almeida RF, Machado L, Duarte MM, Souza DG, Machado P, et al. Effect of a trans fatty acid-enriched diet on biochemical and inflammatory parameters in Wistar rats. Eur J Nutr 2016; 4: 1-14.
35. Bendsen NT, Stender S, Szecsi PB, Pedersen SB, Basu S, Hellgren LI, et al. Effect of industrially produced trans fat on markers of systemic inflammation: evidence from a randomized trial in women. J Lipid Res 2011; 52: 1821-1828. [DOI:10.1194/jlr.M014738]
36. Haghighi ES, Jahromi MK, Daryano Osh F. Relationship between cardiorespiratory fitness, habitual physical activity, body mass index and premenstrual symptoms in collegiate students. J Sports Med Phys Fitness 2015; 55: 663-667.
37. Samadi Z, Taghian F, Valiani M. The effects of 8 weeks of regular aerobic exercise on the symptoms of premenstrual syndrome in non-athlete girls. Iran J Nurs Midwif Res 2013; 18: .
38. Balat O, Dikensoy E, Ugur MG, Atmaca R, Cekmen M, Yurekli M. Malon dialdehyde, nitrite and adrenomedullin levels in patients with premenstrual syndrome. Arch Gynecol Obstet 2007; 275: 361. [DOI:10.1007/s00404-006-0269-1]
39. ET Tuladhar AR. Plasma protein oxidation and total antioxidant power in premenstrual syndrome. Asian Pac J Trop Med 2010; 3: 237-240. [DOI:10.1016/S1995-7645(10)60017-X]
40. Rosenfeld R, Livne D, Nevo O, Dayan L, Milloul V, Lavi S, et al. Hormonal and volume dysregulation in women with premenstrual syndrome. Hypertension 2008; 51: 1225-1230. [DOI:10.1161/HYPERTENSIONAHA.107.107136]
41. Bäckström T, Andreen L, Birzniece V, Björn I, Johansson I-M, Nordenstam-Haghjo M, et al. The role of hormones and hormonal treatments in premenstrual syndrome. CNS Drugs 2003; 17: 325-342. [DOI:10.2165/00023210-200317050-00003]
42. Chuong CJ, Dawson EB. Zinc and copper levels in premenstrual syndrome. Fertil Steril 1994; 62: 313-320. [DOI:10.1016/S0015-0282(16)56884-8]
43. Posaci C, Erten O, Üren A, Acar B. Plasma copper, zinc and magnesium levels in patients with premenstrual tension syndrome. Acta Obstet Gynecol Scand 1994; 73: 452-455. [DOI:10.3109/00016349409013429]
44. Oktem G, Sahin C, Dilsiz OY, Demiray SB, Goker EN, Tavmergen E. Altered Stem Cell Receptor Activity in the Ovarian Surface Epithelium by Exogenous Zinc and/or Progesterone. Drug Res (Stuttg) 2015; 65: 252-258.
45. Du H, Sarno J, Taylor HS. HOXA10 inhibits Kruppel-like factor 9 expression in the human endometrial epithelium. Biol Reprod 2010; 83: 205-211. [DOI:10.1095/biolreprod.110.083980]
46. Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A, et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986; 163: 1433-1450. [DOI:10.1084/jem.163.6.1433]
47. Chao HH, Hong HJ, Cheng TH, Shih NL, Loh SH, Liu JC, et al. Nicorandil Inhibits Cyclic Strain- Induced Interleukin-8 Expression in Human Umbilical Vein Endothelial Cells. Pharmacology 2016; 98: 42-50. [DOI:10.1159/000445075]
48. Das K, Chowdhury AR. Metallic ion concentration during menstrual cycle in normally menstruating women. Indian J Med Sci 1997; 51: 52-54.
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb